Ser54
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser54  -  phosducin (mouse)

Site Information
KEILRQMsSPQSRDD   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 454888

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 3 ) , mass spectrometry ( 2 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 , 3 )
Relevant cell line - cell type - tissue:
C2C12 (myoblast) ( 2 ) , retina ( 3 ) , retinal-retina ( 1 )

Upstream Regulation
Kinases, in vitro:
CAMK2A (human) ( 3 )
Treatments:
light ( 3 ) , microcystin-LR ( 3 ) , okadaic_acid ( 3 )

References 

1

Belcastro M, et al. (2012) Phosphorylation of phosducin accelerates rod recovery from transducin translocation. Invest Ophthalmol Vis Sci 53, 3084-91
22491418   Curated Info

2

Guo A (2009) CST Curation Set: 6160; Year: 2009; Biosample/Treatment: cell line, C2C12/control; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: 9614, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: 1978
Curated Info

3

Song H, Belcastro M, Young EJ, Sokolov M (2007) Compartment-specific phosphorylation of phosducin in rods underlies adaptation to various levels of illumination. J Biol Chem 282, 23613-21
17569665   Curated Info